HIV-associated peripheral neuropathies: a review
Abstract
Objective: To review the various neurologic complications of HIV.
Methods: A MEDLINE search of the English-language literature using a combination of words (HIV, neuropathy and diagnosis) was used to identify original studies, consensus statements and reviews published in the last 25 years.
Results: The various HIV-associated neuropathies are described.
Conclusion: It is important for clinicians to be equipped with the knowledge of the various neuropathic complications of HIV. Prompt diagnosis of these with institution of proper treatment measures would go a long way towards reducing morbidity and mortality outcomes.
Downloads
References
Marco CA, Rothman RE. HIV infection and complications in Emergency Medicine. Emergency Med Clinic North Am. 2008; 26(2):367-387
Sevigny J, Estanislao L.HIV Neurology. In: Current Medical Diagnosis and Treatment 2008. Brust CMJ (Ed), Lange Medical Books 2007, pp 463.
Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, Alexander T, et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus–associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol. 2010; 67(5):552-8.
Jakobsen J, Smith T, Gaub J, Helweg-Larsen S, Trojaborg W. Progressive neurological dysfunction during latent HIV infection. BMJ. 1989; 299(6693):225-228.
Chavanet P, Giroud M, Lancon J, Borsotti JP, Waldner-Combernou AC, Pillon D et al. Altered peripheral nerve conduction in HIV-patients. Cancer Detect Prev. 1988; 12:249-255.
Carr A, Cooper DA. Adverse effect of an anti-retroviral therapy. The Lancet. 2000; 356(9239):1423-1430.
Sadler M, Nelson M .Peripheral neuropathy in HIV. Intl J STD and AIDS. 1997; 8(1):16-22.
Singer EJ, Valdes M, Commins D, Levine A. Neurologic presentations of AIDS. Neurol Clin. 2010; 28(1):253-275.
Martin C, Solders G, Sonnerborg A, Hanson P. Antiretroviral therapy may improve sensory function in HIV-infected patients: a pilot study. Neurology. 2000; 54(1):2120-7.
Estanislao L. HIV myelopathy, peripheral neuropathy and myopathy. In: Clinical Neurovirology, Nath ABJ, (Ed). 2003, Informa Healthcare, New York, pp. 283.
Schifitto G, Yiannoustous C, Simpson DM, Adornato BT, Singer EJ, Hollander H, et al. Long-term treatment with recombinant nerve growth factor for HIVassociated sensory neuropathy. Neurology. 2001; 57(7):1313-1316.
Evans SR, Simpson DM, Kitch DW, King A, Clifford DB, Cohen BA, et al. A randomized trial evaluating Prosaptide for HIV-associated sensoryneuropathies: use of an electronic diary to record neuropathic pain. PLoS ONE. 2007; 2(7):6:e551.
Hahn K, Sirdofsky M, Brown A, Ebenezer G, Hauer P, Miller C, et al. Collateral sprouting of human epidermal nerve fibers following intracutaneous axotomy. J Peripheral Nerv Syst. 2006; 11(2):142-7.
Petorrossi VE, Brunetti V, Carrobi C DellaTorre G, Grassi S. L-acetyl carnitine enhances functional muscle reinnervation. AIDS. 1997; 11(2):185-190.
De Grandis D, Santoro L, Di Benedetto P. L-acetyl carnitine in the treatment of painful peripheral neuropathies in HIV + patients. Clinical Drug Investigation. 1995; 10(6):317-322.
Cherry CL, McArthur JC, Hoy JF, Wesselingh SL. Nucleoside analogues and neuropathy in the era of HAART. J Clinical Virol. 2003; 26(2):195-207.
Fichtenbaum CJ, Clifford DB, Powderly WG. Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. JAIDS. 1995; 10(2):169-174.
Moore RD, Wong WM, Keruly JC, McArthur JC. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS. 2000; 14(3):273-278.
Verma A. Epidemiology and clinical features of HIV‐1 associated neuropathies. J Peripheral Nervous System. 2001; 6(1):8-13.
Brew BJ, Tisch S, Law M. Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy. AIDS. 2003; 17(7):1094-1096.
Arenas-Pinto A, Bhaskaran K, Dunn D, Weller W. The risk of developing peripheral neuropathy induced by nucleoside reverse transcriptase inhibitors decreases over time: evidence from the Delta trial. Antiviral Therapy. 2008; 13(2):289-295.
Lee H, Hanes J, Johnson KA. Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry. 2003; 42(50):14711-14719.
Zhu Y, Antony JM, Martinez JA, Glerum DM, Brussee V, Hoke A, et al. Didanosine causes sensory neuropathy in an HIV/AIDS animal model: impaired mitochondrial and neurotrophic factor gene expression. Brain. 2007; 130(8):2011-2023.
Peltier AC, Russell JW. Recent advances in drug-induced neuropathies. Current Opinion Neurol. 2002; 15(5):633-638.
Canter JA, Haas DW, Kallianpur AR, Ritchie MD, Robbins GK, Shafer RW, et al. The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy. Pharmacogenomics J. 2008; 8:71-77.
Berger AR, Arezzo JC, Schaumburg HH, Skowron G, Merigan T, Bozzette S, et al. 2, 3-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients. Neurology. 1993; 43(2):358-362.
Crabb C. Protease inhibitors and risk of developing HIV-related sensory neuropathy. AIDS. 2004; 18(14):N10.
Kakuda JN. Pharmacology of nucleoside and nucleotide reverse transcriptase induced mitochondrial toxicity. Clinical Therapeutics. 2000; 22(6):685-705.
Moyle G. Toxicity of antiretroviral nucleoside and nucleotide analaogues. Drug Safety. 2000; 23(6):467-481.
Feng JY, Johnson KA, Anderson KS. Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs. J Biol Chem. 2001; 276(26):23832-23837.
Piliero PJ, Fish DG, Preston S, Cunningham D, Kinchelow T, Salgo M, Qian J, Drusano GL. Guillain-Barré syndrome associated with immune reconstitution. Clinical Infec Dis. 2003; 36(9):e111-4.
Piliero PJ, Fish DG, Preston S, Cunningham D, Kinchelow T, Salgo M, et al. Guillain-Barré syndrome associated with immune reconstitution. Clinical Infec Dis. 2003; 36(9):e111-e114.
Brannagan TH, Zhou Y. HIV-associated Guillain-Barré syndrome. J Neurol Sci. 2003; 208(1):39-42.
Cornblath DR, McArthur JC, Kennedy PG, Witte AS, Griffin JW. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol. 1987; (21)1:32-40.
Centner CM, Bateman KJ, Heckmann JM. Manifestations of HIV infection in the peripheral nervous system. Lancet Neurol. 2013; 12(3):295-309.
Soliven B, Roos RP. Acute inflammatory demyelinating polyradiculoneuropathy. Peripheral Neuropathy. 1993; 2:1437-97.
Wulff EA, Wang AK, Simpson DM. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs. 2000; 59(6):1251-1260.
Singer EJ, Valdes-Sueiras M, Commins D, Levine A. Neurologic presentations of AIDS. Neurologic Clinics. 2010; 28(1):253-75.
Cornblath DR, McArthur JC, Kennedy PGE, Witte AS, Griffin JW. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol. 1987; 21(1):32-40.
Simpson D, Estanislao L, Evans S, McArthur JC, Marcus K, Truffa M, et al HIV associated neuromuscular weakness syndrome. AIDS. 2004; 18(10):1403-1412.
Verma S, Misca E, Estanislao L, Simpson D. Neuromuscular complications in HIV. Current Neurol Neurosci Report. 2004; 4(1):62-67.
Berger JR, Simpson DM. The pathogenesis of diffuse infiltrative lymphocytosis syndrome: an AIDS related peripheral neuropathy. Neurol. 1998; 50(4):855-857.
Gherardi RK, Chrétien F, Delfau-Larue MH, Authier FJ, Moulignier A, Roulliard-Dissoux D, et al. Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma Neurology. 1998; 50(4):1041-44.
Itescu S, Brancato LJ, Buxbaum J, Gregersen PK, Rizk CC, Croxson TS, Solomon GE, Winchester R. A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Int Med. 1990; 112(1):3-10.
Moulignier A, Authier FJ, Baudrimont M, Pialoux G, Belec L, Polivka M, et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol. 1997; 41(4):438-45.
Kazi S, Cohen PR, Williams F, Schempp R, Reveille JD. The diffuse infiltrative lymphocytosis syndrome: clinical and immunogenetic features in 35 patients. AIDS. 1996; 10(4):385-92.
Tembl JI, Ferrier JM, Sevilla MT, Lago A, Mayordomo F, Vilchez JJ. Neurologic complications associated with hepatitis C infection. Neurology. 1999; 53(4):861-864.
Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, Hoover DR, et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infec Dis. 1996; 174(4):690-695.
Authier FJ, Pawlotsky JM, Viard JP, Guillevin L, Degos JD, Gherardi RK. High incidence of hepatitis C virus infection in patients with cryoglobulinemic neuropathy. Ann Neurol. 1993; 34(5):749-750.
Vassilopoulos D, Calabrese LH. Hepatitis C infection and vasculitis. Arthritis Rheumatism. 2002; 46(3):585-597.
Miller RG, Storey JR, Greco CM. Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology. 1990; 40(4):569-574.
Lanska MJ, Lanska DJ, Schmidley JW. Syphilitic polyradiculopathy in an HIV-positive man. Neurology. 1988; 38(8):1297-1301.
Leger JM, Henin D, Belec L Mercier B, Cohen L, Bonche P, et al. Lymphoma-induced polyradiculopathy in AIDS: Two cases. J Neurol. 1992; 239(3):132-134.
So YT, Olney RK. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann Neurol. 1994; 35(1):53-58.
Bazan C, Jackson C, Jinkins JR, Barohn RJ. Gadolinium-enhanced MRI in a case of cytomegalovirus polyradiculopathy. Neurology. 1991; 41(9):1522-1523.
Kim YS, Hollander H. Polyradiculopathy due to cytomegalovirus: Report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clinical Infec Dis. 1993; 17(1):32-37.
Miller RF, Fox JD, Thomas P, Waite JC, Sharvell Y, Gazzard BG, et al. Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J Neurol, Neurosurg & Psych. 1996; 61(5):456-460.
So YT, Olney RK. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: Experience in 23 patients. Ann Neurol 1994, 35(1):53-58.
Said G, Goulon-Goeau C, Lacroix C, Feve A, Descamps H, Fouchard M. Inflammatory lesions of peripheral nerve in a patient with human T-lymphotropic virus type I associated myelopathy. Ann Neurol. 1988; 24(2):275-277.
Nascimento OJ, Marques Jr W. Human T-cell leukemia virus (HTLV)-associated neuropathy. Handbook of Clinical Neurology 2013; 115:531.
Funamoto K, Takada K, Inoue K, Sawada Y, Araga s, Takayashi K. Peripheral nerve involvement in HTLV-I-associated myelopathy: report of a case. Japanese J Med. 1989; 28(6):762-4.
Harrison LH, Vaz B, Taveira DM, Taveira DM, Quinn TC, Gibbs CJ, et al. Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV. Neurology. 1997; 48(1):13-18.
McArthur JC, Griffin JW, Cornblath DR, Griffin DE, TesorieroT, Kuncl R, et al. Steroid responsive myeloneuropathy in a man dually infected with HIV-I and HTLV-I. Neurology. 1990; 40(6):938-944.
McDougal JS, Hubbard M, Nicholson JK, Jones BM, Holman RC, Roberts J, et al. Immune complexes in the acquired immunodeficiency syndrome (AIDS); its relationship to disease manifestation, risk group, and immunologic defect. J Clinical Immunol. 1985; 5(2):130-8.
Chaunu M, Ratinahirana H, Raphael M. The spectrum of changes on 20 nerve biopsies in patients with HIV infection. Muscle Nerve. 1989; 12(6):452-9.
Lipkin WI, Parry G, Kiprov D, Abrams D. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology. 1985; 35(10):1479-1483.
OAI - Open Archives Initiative
